BE-86-FY67_0.01uM Gene Set

Dataset NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles
Category transcriptomics
Type drug perturbation
Description Dose=0.01uM, Enoxolone, 11-beta-Hydroxysteroid Dehydrogenase Type 2 (11beta-HSD2) Inhibitors;17beta-Hydroxysteroid Dehydrogenase Type 3 (17beta-HSD3) Inhibitors;11-beta-Hydroxysteroid Dehydrogenase Type 1 (11beta-HSD1) Inhibitors targeting HSD11B1, HSD11B2, HSD17B3 (Novartis, 10114)
External Link https://pubchem.ncbi.nlm.nih.gov/compound/10114
Similar Terms
Downloads & Tools

Genes

23 genes differentially expressed following the BE-86-FY67_0.01uM drug perturbation from the NIBR DRUG-seq U2OS MoA Box dataset.

increased expression

Symbol Name Standardized Value
RPL31 ribosomal protein L31 0.829365
RPS3A ribosomal protein S3A 0.323144
RPS13 ribosomal protein S13 0.323144
PSMA4 proteasome (prosome, macropain) subunit, alpha type, 4 0.323144
UQCRQ ubiquinol-cytochrome c reductase, complex III subunit VII, 9.5kDa 0.28434
RPS24 ribosomal protein S24 0.244606
PRDX1 peroxiredoxin 1 0.222816
RPS23 ribosomal protein S23 0.222816
RPL22 ribosomal protein L22 0.218674
RPL35 ribosomal protein L35 0.213302
BEST1 bestrophin 1 0.202704
SRP14 signal recognition particle 14kDa (homologous Alu RNA binding protein) 0.202028
GGT1 gamma-glutamyltransferase 1 0.202028

decreased expression

Symbol Name Standardized Value
OAZ1 ornithine decarboxylase antizyme 1 -0.333173
CDC42EP1 CDC42 effector protein (Rho GTPase binding) 1 -0.323144
CSK c-src tyrosine kinase -0.240618
SRMS src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites -0.230553
ESYT1 extended synaptotagmin-like protein 1 -0.222816
PMEPA1 prostate transmembrane protein, androgen induced 1 -0.213302
LZTS3 leucine zipper, putative tumor suppressor family member 3 -0.213302
DVL1 dishevelled segment polarity protein 1 -0.213302
HAPLN3 hyaluronan and proteoglycan link protein 3 -0.205924
ZYX zyxin -0.204329